← Browse by Condition
Medical Condition

rectal cancer

Total Trials
19
Recruiting Now
19
Trial Phases
Phase 3, Phase 2, Phase 1
NCT04495088 Phase 3
Recruiting

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Enrollment
550 pts
Location
Germany
Sponsor
Ralf Hofheinz
View Trial →
NCT05672524 Phase 2
Recruiting

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Enrollment
37 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT05938322
Recruiting

Ketogenic Diet Compliance in Patients Undergoing Radiotherapy for Pelvic Cancers

Enrollment
194 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
View Trial →
NCT06366841
Recruiting

Stigma and Psychological profilE in REctal-anal caNcer pAtients

Enrollment
148 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
View Trial →
NCT05563922 Phase 2
Recruiting

Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma

Enrollment
56 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
View Trial →
NCT05939661 Phase 2
Recruiting

A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer

Enrollment
45 pts
Location
Japan
Sponsor
Osaka University
View Trial →
NCT03466424
Recruiting

Short-course Radiotherapy (5×6Gy/7Gy/8Gy) Followed by Neo-adjuvant Chemotherapy for Locally Advanced Rectal Cancer

Enrollment
9 pts
Location
China
Sponsor
Fujian Medical University Unio...
View Trial →
NCT05556473 Phase 1
Recruiting

F-Tryptophan PET/CT in Human Cancers

Enrollment
24 pts
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In...
View Trial →
NCT06536127
Recruiting

Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer

Enrollment
100 pts
Location
France
Sponsor
Institut Sainte Catherine
View Trial →
NCT07227636 Phase 2
Recruiting

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

Enrollment
284 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT06210971 Phase 2
Recruiting

Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer

Enrollment
60 pts
Location
China
Sponsor
Hebei Medical University Fourt...
View Trial →
NCT06501053
Recruiting

Contact Radiotherapy for Rectal Cancer

Enrollment
110 pts
Location
Sweden
Sponsor
Alexander Valdman
View Trial →
NCT06577194 Phase 2
Recruiting

A Single-Center, Single-Arm Study of Neoadjuvant Short-Course Radiotherapy With IL-2 Followed by Sequential Immunotherapy With CAPOX Combined With PD-1 Antibody and IL-2 for Locally Advanced Rectal Cancer

Enrollment
35 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT06162650 Phase 2
Recruiting

Total Neoadjuvant Therapy in Rectal Cancer

Enrollment
42 pts
Location
Taiwan
Sponsor
National Cheng-Kung University...
View Trial →
NCT05052086
Recruiting

Magnetomotoric Ultrasound (MMUS) in Rectal Cancer

Enrollment
60 pts
Location
Sweden
Sponsor
Region Skane
View Trial →
NCT06923150
Recruiting

A Randomised Clinical Investigation to Assess Efficacy of Low Volume Transanal Irrigation by Qufora® IrriSedo MiniGo Versus Conservative Treatment for Low Anterior Resection Syndrome Patients

Enrollment
78 pts
Location
France
Sponsor
Qufora A/S
View Trial →
NCT05049317
Recruiting

Multicenter Study on Postoperative Urinary and Sexual Function During Laparoscopic Functional Total Mesorectum Excision

Enrollment
88 pts
Location
China
Sponsor
Renmin Hospital of Wuhan Unive...
View Trial →
NCT06340646
Recruiting

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

Enrollment
990 pts
Location
United States
Sponsor
Washington University School o...
View Trial →
NCT05434026
Recruiting

Chinese Colorectal Cancer Database

Enrollment
200,000 pts
Location
China
Sponsor
Beijing Friendship Hospital
View Trial →